Marksans Pharma (MARKSANS): Press Release

Press Release Marksans Pharma Limited has informed the Exchange regarding a press release dated Jun 01, 2026, titled "Marksans Pharma to Acquire 100% of Netherlands-based QliniQ B.V., Strengthening Presence in European Markets". Marksans Pharma Limited has informed the Exchange regarding a press release dated Jun 01, 2026, titled "Marksans Pharma to Acquire 100% of Netherlands-based QliniQ B.V., Strengthening Presence in European Markets". Marksans Pharma Limited has informed the Exchange reg

1 min read Marksans Pharma

Press Release

Press Release

Marksans Pharma Limited has informed the Exchange regarding a press release dated Jun 01, 2026, titled "Marksans Pharma to Acquire 100% of Netherlands-based QliniQ B.V., Strengthening Presence in European Markets".

Marksans Pharma Limited has informed the Exchange regarding a press release dated Jun 01, 2026, titled "Marksans Pharma to Acquire 100% of Netherlands-based QliniQ B.V., Strengthening Presence in European Markets".

Marksans Pharma Limited has informed the Exchange regarding a press release dated Jun 01, 2026, titled "Marksans Pharma to Acquire 100% of Netherlands-based QliniQ B.V., Strengthening Presence in European Markets".

Disclaimer

This article is for informational purposes only and is not investment advice. Verify all figures and announcements from official exchange filings and company disclosures before making decisions.

#MARKSANS PHARMA LTD #MARKSANS #Corporate announcement

Live Updates

Quick Notification

AI Insights

Smart analysis of market trends

Smart Alerts

Notifications on crucial events

WhatsApp & Telegram

Alerts in the chat you already use

FREE PLAN · PAID UPGRADES FROM ₹89/MO

Track Indian stocks with ZTOX AI

NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.

Free 5 companies
Basic 20 companies
Pro Up to 500 companies
A

"ZTOX has transformed how I track companies. The real-time alerts and AI insights save me hours of research every day."

— Aditya M., Active Trader